Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Most cited article(s)

  • 
    Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
    You have access
    Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
    Justin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, Manuel Weber, Nader Hirmas, Karina Kostbade, Sebastian Bauer, Martin Schuler, Marit Ahrens, Hans-Ulrich Schildhaus, Christoph Rischpler, Hong Grafe, Jens T. Siveke, Ken Herrmann, Wolfgang P. Fendler and Rainer Hamacher
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 727-734; DOI: https://doi.org/10.2967/jnumed.121.262468
  • Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
    You have access
    Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
    Guobao Wang, Lorenzo Nardo, Mamta Parikh, Yasser G. Abdelhafez, Elizabeth Li, Benjamin A. Spencer, Jinyi Qi, Terry Jones, Simon R. Cherry and Ramsey D. Badawi
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1274-1281; DOI: https://doi.org/10.2967/jnumed.121.262668
  • Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
    You have access
    Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
    Jeremie Calais, Andrei Gafita, Matthias Eiber, Wesley R. Armstrong, Jeannine Gartmann, Pan Thin, Kathleen Nguyen, Vincent Lok, Laura Gosa, Tristan Grogan, Rouzbeh Esfandiari, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, David Ranganathan, Roger Slavik, Magnus Dahlbom, Ken Herrmann, Ebrahim Delpassand, Wolfgang P. Fendler and Johannes Czernin
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1440-1446; DOI: https://doi.org/10.2967/jnumed.121.261982
  • You have access
    Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
    Phillip H. Kuo, Taylor Benson, Richard Messmann and Michael Groaning
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 816-818; DOI: https://doi.org/10.2967/jnumed.121.263638
  • <sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational Trial
    You have access
    68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
    Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Sebastian Bauer, Uta Dirksen, Fadi Zarrad, Michael Nader, Michal Chodyla, Aleksandar Milosevic, Lale Umutlu, Martin Schuler, Lars Erik Podleska, Hans-Ulrich Schildhaus, Wolfgang P. Fendler and Rainer Hamacher
    Journal of Nuclear Medicine January 1, 2022, 63 (1) 89-95; DOI: https://doi.org/10.2967/jnumed.121.262096
  • Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using <sup>177</sup>Lu-FAP-2286: First-in-Humans Results
    Open Access
    Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
    Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
  • Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
    You have access
    Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
    Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808
  • Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study
    You have access
    Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study
    Manuel Röhrich, Dominik Leitz, Frederik M. Glatting, Annika K. Wefers, Oliver Weinheimer, Paul Flechsig, Nicolas Kahn, Marcus A. Mall, Frederik L. Giesel, Clemens Kratochwil, Peter E. Huber, Andreas von Deimling, Claus Peter Heußel, Hans Ulrich Kauczor, Michael Kreuter and Uwe Haberkorn
    Journal of Nuclear Medicine January 1, 2022, 63 (1) 127-133; DOI: https://doi.org/10.2967/jnumed.121.261925
  • Correlation of <sup>68</sup>Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
    Open Access
    Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
    Christine E. Mona, Matthias R. Benz, Firas Hikmat, Tristan R. Grogan, Katharina Lueckerath, Aria Razmaria, Rana Riahi, Roger Slavik, Mark D. Girgis, Giuseppe Carlucci, Kimberly A. Kelly, Samuel W. French, Johannes Czernin, David W. Dawson and Jeremie Calais
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1021-1026; DOI: https://doi.org/10.2967/jnumed.121.262426
  • Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
    Open Access
    Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
    Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire